Kotch, C.; Wagner, K.; Broad, J.H.; Dombi, E.; Minturn, J.E.; Phillips, P.; Smith, K.; Li, Y.; Jacobs, I.N.; Elden, L.M.;
et al. Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study. Cancers 2023, 15, 2621.
https://doi.org/10.3390/cancers15092621
AMA Style
Kotch C, Wagner K, Broad JH, Dombi E, Minturn JE, Phillips P, Smith K, Li Y, Jacobs IN, Elden LM,
et al. Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study. Cancers. 2023; 15(9):2621.
https://doi.org/10.3390/cancers15092621
Chicago/Turabian Style
Kotch, Chelsea, Kristina Wagner, J. Harris Broad, Eva Dombi, Jane E. Minturn, Peter Phillips, Katherine Smith, Yimei Li, Ian N. Jacobs, Lisa M. Elden,
and et al. 2023. "Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study" Cancers 15, no. 9: 2621.
https://doi.org/10.3390/cancers15092621
APA Style
Kotch, C., Wagner, K., Broad, J. H., Dombi, E., Minturn, J. E., Phillips, P., Smith, K., Li, Y., Jacobs, I. N., Elden, L. M., Fisher, M. J., & Belasco, J.
(2023). Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 Study. Cancers, 15(9), 2621.
https://doi.org/10.3390/cancers15092621
